Jyong Biotech Ltd. Successfully Raises $20 Million From Nasdaq IPO to Enter $11.9 Billion Urology Health Market

Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).

Scientists want to create human DNA from scratch - but is it ethical to do?

'Making a whole human genome from scratch would be a gargantuan feat.'

AIR1 & AIX Successfully Host the 2025 Global Strategy Launch, Ushering in a New Era of Decentralized Computing Power

GoldEx: Fast, stable, and intelligent, leading a new financial experience

CRCC Develops Local Expertise in Tanzania

Map shows safest countries to be in if world war breaks out

With the US joining Israel in strikes on Iran, we take a look at where you might want to head if the conflict escalates.